Sponsor pipeline

EyeGene Inc. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2/3

NCT ID	Title	Condition	Status	Updated
Phase 2/3
NCT07204457	Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults…	Meningococcal Infections	Recruiting	2025-12-01

Get alerts when EyeGene Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.